QUANTITATIVE THRESHOLDS OF MHC CLASS-II I-E EXPRESSED ON HEMOPOIETICALLY DERIVED ANTIGEN-PRESENTING CELLS IN TRANSGENIC NOD LT MICE DETERMINE LEVEL OF DIABETES RESISTANCE AND INDICATE MECHANISM OF PROTECTION/
Ms. Hanson et al., QUANTITATIVE THRESHOLDS OF MHC CLASS-II I-E EXPRESSED ON HEMOPOIETICALLY DERIVED ANTIGEN-PRESENTING CELLS IN TRANSGENIC NOD LT MICE DETERMINE LEVEL OF DIABETES RESISTANCE AND INDICATE MECHANISM OF PROTECTION/, The Journal of immunology, 157(3), 1996, pp. 1279-1287
Two homozygous lines of transgenic NOD/Lt mice expressing MHC class II
I-E molecules at quantitatively different levels were utilized to stu
dy mechanisms of I-E-mediated diabetes prevention. In line 12, I-E exp
ression on APC at levels comparable with that in BALB/cByJ controls co
nferred only partial diabetes resistance, In line 5, greater than norm
al I-E levels on APC correlated with nearly complete resistance. Level
s of endogenously encoded I-A(g7) correlated inversely with transgene-
induced I-E expression, T cell transfer experiments into NOD/severe co
mbined immunodeficient mice demonstrated the presence of pathogenic T
cells in I-E(+) donors, and that continuous expression of I-E on hemop
oietically derived APC was required to block their pathogenic function
. T cells from transgenic and nontransgenic NOD/Lt mice primed in vivo
against the beta cell autoantigen 65-kDa isoform of glutamic acid dec
arboxylase (GAD65) and two peptides derived from this protein prolifer
ated when restimulated in vitro. However, reverse-transcription PCR an
d ELISA measurements of cytokine mRNA and protein levels showed that t
he GAD65-reactive T cells from both line 5 and line 12 mice produced h
igher levels of IL-4 and lower levels of IFN-gamma than similar T cell
s from standard NOD/Lt mice. Thus, the inverse relationship between I-
E and I-A(g7) expression was associated with qualitative differences i
n T cell responses to putative beta cell autoantigens. collectively, t
hese data indicate quantitative increases in I-E expression on APC may
block insulin-dependent diabetes mellitus by altering the balance of
cytokines produced by beta cell autoreactive T cells.